EO 14398

Ended Indefinite Delivery Contract Awarded Last action

Contract number
HHSN272201700010I
Awardee
Awarding agency
Task orders
19 $80,756,314 obligated

Award facts

Opportunity
Combined order value
  • $82,840,884 Current, with exercised options
  • $91,037,320 Potential, with all options
Last date to order 100% complete
IDV ceiling 25% used
$318,500,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

About this IDV

The National Institute of Allergy and Infectious Diseases awarded a single-award indefinite delivery contract to Advanced Bioscience Laboratories, Inc. on June 8, 2017, with a ceiling of $318.5 million for preclinical development support services. The contract ultimately completed on June 9, 2024.

Work was performed in Rockville, Maryland. The IDIQ supported NIAID's preclinical development initiatives spanning cGMP manufacturing of vaccines and biologics, process development, analytical testing, stability studies, quality assurance, project management, and related services for infectious disease countermeasures including HIV, influenza, and other vaccines and therapeutics.

Delivery orders issued under this IDIQ included cGMP manufacturing of monoclonal antibodies (PGT121.414.LS, PGT121, and PGDM1400); glycopeptide immunogen nanoparticle vaccines; HIV-1 envelope glycopeptide and bulk harvest production; ALVAC-HIV drug product and diluent; adjuvant production (aluminum-based, delta inulin, and CPG adjuvants); fill-finish and stability testing of HIV-1 gp120 proteins; procurement of cGMP QS21 and ALF55 drug substance; downstream engineering and cGMP manufacturing; long-term stability testing of nanoparticle-based HIV envelope vaccines; and essential core activities support. Notable task orders included a $17.2 million order for PGT121.414.LS manufacturing and fill-finish (issued June 10, 2017, completing December 30, 2028), a $12.9 million order for PGT121 and PGDM1400 antibody manufacturing (issued August 9, 2018, completing December 31, 2031), and a $8.9 million order for ALVAC-HIV production (issued September 11, 2018, completing August 31, 2023).

Task orders

Task order Ordering agency Obligated Awarded
The contractor shall provide support for essential activities that are to be performed on a regular basis. This… 75N93022F00002 National Institute of Allergy and Infectious Diseases (NIH) $1,467,826
Stability testing of antibodies and reagents used in downstream process purification 75N93021F00001 National Institute of Allergy and Infectious Diseases (NIH) $165,272
This task order is for (a) downstream engineering run production, (b) downstream current good manufacturing practices… 75N93021F00002 National Institute of Allergy and Infectious Diseases (NIH) $6,721,455
Procurement of cgmp QS21 and production of cgmp ALF55 drug substance 75N93020F00117 National Institute of Allergy and Infectious Diseases (NIH) $1,782,227
Cgmp manufacturing of glycopeptide immunogen nanoparticle vaccine 75N93019F00132 National Institute of Allergy and Infectious Diseases (NIH) $4,683,305
R & d- medical: aids research (management/support) 75N93019F00131 National Institute of Allergy and Infectious Diseases (NIH) $2,857,610
Niaid preclinical development support; synthesize and produce HIV-1 envelope glycpeptide immunogen nanoparticle… 75N93018F00005 National Institute of Allergy and Infectious Diseases (NIH) $2,959,434
Niaid preclinical development support: production of alvac-HIV drug product and diluent 75N93018F00008 National Institute of Allergy and Infectious Diseases (NIH) $6,846,036
Niaid preclinical development support - niaid preclinical development support: production and procurement of delta… 75N93018F00011 National Institute of Allergy and Infectious Diseases (NIH) $2,407,110
Niaid preclinical development support- cgmp manufacturing of PGT121 and PGDM1400 antibodies 75N93018F00009 National Institute of Allergy and Infectious Diseases (NIH) $12,942,880
Cgmp production of HIV-1 envelope (ENV) bulk harvest HHSN27200004 National Institute of Allergy and Infectious Diseases (NIH) $2,696,523
Production of adjuvants HHSN27200006 National Institute of Allergy and Infectious Diseases (NIH) $1,458,937
Niaid preclinical development support HHSN27200007 National Institute of Allergy and Infectious Diseases (NIH) $2,044,103
Fill-finish, release, and stability testing of HIV-1 GP120 proteins $2,302,002 on can 17-8470035. HHSN27200002 National Institute of Allergy and Infectious Diseases (NIH) $3,017,609
Production of aluminum based adjuvants HHSN27200003 National Institute of Allergy and Infectious Diseases (NIH) $18,048
Essential core activities III 75N93024F00001 National Institute of Allergy and Infectious Diseases (NIH) $1,555,875
Long-term stability testing of a nanoparticle based HIV envelope containing vaccine 75N93024F00002 National Institute of Allergy and Infectious Diseases (NIH) $804,692
The task order is to support cgmp manufacturing of the PGT121.414.LS monoclonal antibody (PGT121.414.LS MAB) drug… 75N93023F00001 National Institute of Allergy and Infectious Diseases (NIH) $17,241,407
Essential core activities, niaid preclin development support HHSN27200001 National Institute of Allergy and Infectious Diseases (NIH) $9,085,963
Show all 19

Transactions

Action Obligated Date
Other Administrative Action P00007 $0
Other Administrative Action P00006 $0
Other Administrative Action P00005 · Niaid preclinical development support $0
Other Administrative Action P00004 $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award Niaid preclinical development support $0

Quick answers

Who was awarded contract HHSN272201700010I?

HHSN272201700010I was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 8, 2017.

How much is contract HHSN272201700010I worth?

Orders under HHSN272201700010I have obligated $80,756,314. Their combined current value, with exercised options, is $82,840,884. Their combined potential value, with all options, is $91,037,320. HHSN272201700010I's own ceiling is $318,500,000.

How many orders have been placed under contract HHSN272201700010I?

19 orders have been placed under HHSN272201700010I, the latest on June 10, 2022.

Who can order from contract HHSN272201700010I?

HHSN272201700010I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract HHSN272201700010I competed?

The extent of competition for HHSN272201700010I was full and open competition. The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV